Afficher la notice abrégée

A pilot study of an accelerometer-equipped smartphone to monitor older adults with cancer receiving chemotherapy in Mexico

dc.rights.licenseopenen_US
dc.contributor.authorSOTO-PEREZ-DE-CELIS, E.
dc.contributor.authorKIM, H.
dc.contributor.authorROJO-CASTILLO, M. P.
dc.contributor.authorSUN, C. L.
dc.contributor.authorCHAVARRI-GUERRA, Y.
dc.contributor.authorNAVARRETE-REYES, A. P.
dc.contributor.authorWAISMAN, J. R.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorAVILA-FUNES, Jose Alberto
dc.contributor.authorAGUAYO, A.
dc.contributor.authorHURRIA, A.
dc.date.accessioned2021-01-05T13:06:22Z
dc.date.available2021-01-05T13:06:22Z
dc.date.issued2018-03
dc.identifier.issn1879-4076 (Electronic) 1879-4068 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/23664
dc.description.abstractEnOBJECTIVES: Older adults with cancer in developing countries face challenges accessing healthcare due to a lack of personnel and infrastructure. A decline in physical activity (defined as a decrease in the number of daily steps) may be a novel method for the timely detection of toxicity in older adults receiving chemotherapy in resource-constrained settings. MATERIALS AND METHODS: In this feasibility study, patients aged >/=65years starting first-line chemotherapy for solid tumors were given a smartphone with a pedometer application. Daily steps were monitored daily for one cycle. If a >/=15% decrease from baseline was identified, the patient was called and the presence of toxicity assessed. The intervention would be feasible if >/=75% of the subjects recorded steps for >/=75% of the planned chemotherapy days. RESULTS: Forty patients (median age 73; 57% [N=23] female) were included. Seventy percent (N=28) had stage III-IV disease with 45% (N=18) gastrointestinal, 23% (N=9) breast, and 32% (N=13) other malignancies. Mean pre-treatment daily steps was 3111 (Standard Deviation [SD] 1731), and median follow-up was 21days (range 2-28). Despite having limited exposure to mobile technology, most (93%) patients used the smartphone appropriately, and 85% found it easy to use. Sixty percent of patients (N=24) had toxicities managed over the phone, 27.5% (N=10) were sent for urgent medical attention and 15% (N=6) were hospitalized. CONCLUSION: Using smartphones to monitor older adults with cancer receiving chemotherapy in a resource-constrained setting is feasible and acceptable. A decrease in the number of daily steps was common and helped to identify chemotherapy toxicity.
dc.language.isoENen_US
dc.subject.enSEPIA
dc.title.enA pilot study of an accelerometer-equipped smartphone to monitor older adults with cancer receiving chemotherapy in Mexico
dc.title.alternativeJ Geriatr Oncolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.jgo.2017.09.008en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed29017891en_US
bordeaux.journalJournal of Geriatric Oncologyen_US
bordeaux.page145-151en_US
bordeaux.volume9en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue2en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamSEPIAen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03193157
hal.version1
hal.date.transferred2021-04-08T13:42:49Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Geriatric%20Oncology&rft.date=2018-03&rft.volume=9&rft.issue=2&rft.spage=145-151&rft.epage=145-151&rft.eissn=1879-4076%20(Electronic)%201879-4068%20(Linking)&rft.issn=1879-4076%20(Electronic)%201879-4068%20(Linking)&rft.au=SOTO-PEREZ-DE-CELIS,%20E.&KIM,%20H.&ROJO-CASTILLO,%20M.%20P.&SUN,%20C.%20L.&CHAVARRI-GUERRA,%20Y.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée